GATC Biotech Lifts Next Generation Sequencing Services to the Next Level with NGSelect™

GATC Biotech has announced the launch of NGSelect - a novel modular system for next generation sequencing (NGS) applications for power users. It is a comprehensive solution that can be personalized by researchers, enabling them to either gain access to sequencing capacity alone or to combine additional services according to the modular concept.

”Apart from the modular design of a sequencing project, one big benefit we see is that scientists can gain access to sequence capacity for a good price. This provides them with a higher planning reliability and highly competitive delivery times, e.g. in times of shortages in sequencing capacities of their own in- house facilities.” said Peter Pohl, co-founder and CEO. “In addition, our innovative product is providing a new dimension of utility for our customers. Modules based on state-of-the-art technology and fully automated and streamlined workflows, offer the highest flexibility and performance. That helps to accelerate NGS projects and increase data reliability, by lowering the project costs at once.”

NGSelect lifts NGS services to a new level complementing GATC Biotech’s Sequencing Solutions. It broadens the range of applications to enable scientists to use cost-efficient, standardised modules depending on their particular project requirements.

“Our InViewTM portfolio of standardized products for NGS includes innovative solutions for the key areas our customers are working in. NGSelect is the logical and innovative step to complete our portfolio of Sequencing Solutions,” added Peter Pohl.